In this, the fifth in our ‘TB Talk’ series of episodes, we hear from Dr. Ryan Cooper, an infectious diseases specialist with Alberta Health Services. Here, Dr. Cooper speaks to how post-landing TB surveillance works in Canada (including some Alberta-specific challenges), plus the best approach to on-going follow-up. He also discusses how Alberta’s virtual TB clinic model has made a difference to rural, remote and Indigenous communities.
The fourth in our ‘TB Talk’ series, conversations from the most recent meeting of the North American Region of the International Union Against Tuberculosis. This episode, we hear from Dr. Dennis Falzon, a Medical Officer with the Stop TB Department at the World Health Organization in Geneva. Here, he discusses the WHO’s End TB Strategy, as well as the potential of new technologies to prevent and eliminate TB.
The third in our ‘TB Talk’ series, we hear from Dr. Malcolm King, a professor in the Faculty of Health Sciences at Simon Fraser University. He discusses the importance of social determinants of health to the rate of new TB infections and better TB outcomes in remote, northern and Indigenous communities.
This episode continues our look at tuberculosis at End TB 2017, a meeting of the North American Region of the International Union Against Tuberculosis. Our guest, Kay Wallis, is a special projects manager with the Curry International Tuberculosis Center. She presented on cultural proficiency among healthcare providers, or, as she calls it, cultural humility.
This episode, we turn our attention to tuberculosis. This February, the city of Vancouver played host to End TB 2017, a meeting of the International Union Against Tuberculosis, specifically, the North American Region. We hear a sample of attendees’ top TB priorities. In future episodes, we’ll bring you a number of one-on-one conversations with experts at the meeting.
Join three of Canada’s prominent physicians, Drs. Allan Ronald, Joel Kettner and Julio Montaner, for a webinar that explores the topic of Treatment as Prevention for TB, Hepatitis C and HIV/AIDS.